Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > We seem to have reached a bottom

<< Previous

Bullboard Posts

Next >>

Post by tylerreddickon Apr 25, 2024 9:27am

113 Views

Post# 36006820

We seem to have reached a bottom

There had to be an end to the slide in the share price, and it appears we have reached that level.
If this company has success with either AbbVie or Sirona Labs, buying at this level will be a life-changer. I know, that is a BIG "if", but you never know. :o)

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading